Utilizing a passionate and talented team, VoxCell is creating an extraordinary line of solutions for the drug development industry and the field of Oncology research. We offer three core products: a unique 3D Bioprinter, Novel Bioinks, and Tissue Models for in vitro drug testing. Our 3D Bioprinter uses a state of the art laser with a process that crosslinks bioink with extreme precision, producing incredible high resolution 3D printed tissues. This process occurs only at the focal point of the laser (the voxel, hence VoxCell), allowing for printing anywhere in the polymer, including within structures, unlike traditional extrusion based 3D bio/printers.
Our printer will produce highly detailed sub-micrometer tissue models with vasculature, mimicking human tissue, for in vitro drug testing and is aimed to increase the successful translation between pre-clinical trial data and clinical trial results - currently less than 8%!
Testing on truly biomimetic tissues will provide better data to identify and eliminate unsuccessful drug candidates sooner, increasing the throughput and reducing the volume and cost of animal and human testing, ultimately getting life saving therapies to market and in the hands of people who need them sooner.